Cargando…

Prognostic value of pretreatment Controlling Nutritional Status score in esophageal cancer: a meta-analysis

Background and purpose: The association between the pretreatment Controlling Nutritional Status (CONUT) score and the prognosis of esophageal cancer patients remains unclear. The aim of this meta-analysis was to further elucidate the prognostic role of the pretreatment CONUT score in esophageal canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Jing, Chen, Peirui, Wu, Jianqiang, Hu, Caihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pathology and Oncology Archive
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333492/ https://www.ncbi.nlm.nih.gov/pubmed/37441713 http://dx.doi.org/10.3389/pore.2023.1611221

Ejemplares similares

Prognostic Value of Glasgow Prognostic Score in Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Chuan-Long, et al.
Publicado: (2022)

Prognostic role of pretreatment skeletal muscle index in gastric cancer patients: A meta-analysis
por: He, Xiaohong, et al.
Publicado: (2023)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
por: Li, Yan, et al.
Publicado: (2022)

Prognostic value of albumin-bilirubin score in pancreatic cancer patients after pancreatoduodenectomy with liver metastasis following radiofrequency ablation
por: Zhang, Lei, et al.
Publicado: (2023)

Prognostic Value of Pretreatment Controlling Nutritional Status Score for Patients With Pancreatic Cancer: A Meta-Analysis
por: Ma, Xiaofeng, et al.
Publicado: (2022)

Cohort size required for prognostic genes analysis of stage II/III esophageal squamous cell carcinoma
por: Kong, Linghong, et al.
Publicado: (2023)

Immunological role and prognostic value of SPARCL1 in pan-cancer analysis
por: He, Kangwei, et al.
Publicado: (2022)

IL-33 Participates in the Development of Esophageal Adenocarcinoma
por: Liu, Jia, et al.
Publicado: (2022)

Expression and Potential Prognostic Value of SOX9, MCL-1 and SPOCK1 in Gastric Adenocarcinoma
por: Luo, Wenyi, et al.
Publicado: (2022)

Prognostic Value of Highly Expressed Type VII Collagen (COL7A1) in Patients With Gastric Cancer
por: Oh, Sung Eun, et al.
Publicado: (2021)

Case Report: Potential Predictive Value of MMR/MSI Status and PD-1 Expression in Immunotherapy for Urothelial Carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2022)

Corrigendum: Case report: Potential predictive value of MMR/MSI status and PD-1 expression in immunotherapy for urothelial carcinoma
por: Ma, Yu-Ting, et al.
Publicado: (2023)

Prognostic Signature of Osteosarcoma Based on 14 Autophagy-Related Genes
por: Qi, Wei, et al.
Publicado: (2021)

Pretreatment Systemic Immune-Inflammation Index Can Predict Response to Neoadjuvant Chemotherapy in Cervical Cancer at Stages IB2-IIB
por: Liu, Pingping, et al.
Publicado: (2022)

The Prognostic Value of Eight Immunohistochemical Markers Expressed in the Tumor Microenvironment and on Hodgkin Reed-Sternberg Cells in Pediatric Patients With Classical Hodgkin Lymphoma
por: Zijtregtop, Eline A. M., et al.
Publicado: (2022)

Prognostic value of long non-coding RNA MALAT1 in hepatocellular carcinoma: A study based on multi-omics analysis and RT-PCR validation
por: Liao, Xiaoli, et al.
Publicado: (2023)

Pretreatment C-Reactive Protein/Albumin Ratio is Associated With Poor Survival in Patients With 2018 FIGO Stage IB-IIA HPV-Positive Cervical Cancer
por: Jiang, Yinan, et al.
Publicado: (2021)

Glutamine Metabolism Scoring Predicts Prognosis and Therapeutic Resistance in Hepatocellular Carcinoma
por: Ying, Leqian, et al.
Publicado: (2021)

The Prognostic Role of PORT and EGFR Mutation Status in Completely Resected Stage IIIA/N2 Non-Small Cell Lung Cancer Patients with Postoperative Chemotherapy
por: Yang, Hui, et al.
Publicado: (2021)

Long Non-Coding RNA in Esophageal Cancer: A Review of Research Progress
por: Yang, Chenbo, et al.
Publicado: (2022)

Cytokine-induced killer cell treatment is superior to chemotherapy alone in esophageal cancer
por: Sun, Jiayang, et al.
Publicado: (2023)

Clinicopathological Features and Prognostic Evaluation of UBR5 in Liver Cancer Patients
por: Huo, Qi, et al.
Publicado: (2022)

Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy
por: Tan, Shirong, et al.
Publicado: (2021)

Clinical Significance of Fusobacterium nucleatum Infection and Regulatory T Cell Enrichment in Esophageal Squamous Cell Carcinoma
por: Zhang, Ning, et al.
Publicado: (2021)

Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma
por: Li, Hui, et al.
Publicado: (2023)

Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing
por: Zhao, Xu, et al.
Publicado: (2021)

A Risk Model Based on Immune-Related Genes Predicts Prognosis and Characterizes the Immune Landscape in Esophageal Cancer
por: Xie, Yan, et al.
Publicado: (2022)

Prognostic value of prognostic nutritional index score and controlling nutritional status score in patients with glioblastoma: A comprehensive meta-analysis
por: Peng, Jie, et al.
Publicado: (2023)

Diagnostic Value of Six Tumor Markers for Malignant Pleural Effusion in 1,230 Patients: A Single-Center Retrospective Study
por: Fan, Xin, et al.
Publicado: (2022)

Associations of Porphyromonas gingivalis Infection and Low Beclin1 Expression With Clinicopathological Parameters and Survival of Esophageal Squamous Cell Carcinoma Patients
por: Guo, Yibo, et al.
Publicado: (2021)

APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis
por: Cao, Xiying, et al.
Publicado: (2023)

A Novel Prognostic Factor TIPE2 in Bladder Cancer
por: Jiang, Yu, et al.
Publicado: (2022)

Integrated oxidative stress score for predicting prognosis in stage III gastric cancer undergoing surgery
por: Liu, Yu-hang, et al.
Publicado: (2023)

RCC1 Expression as a Prognostic Marker in Colorectal Liver Oligometastases
por: Deng, Yuxiang, et al.
Publicado: (2021)

Prevalence and Prognostic Implications of PD-L1 Expression in Soft Tissue Sarcomas
por: Kelany, Mohamed, et al.
Publicado: (2021)

Prognostic Analysis of Differentially Expressed DNA Damage Repair Genes in Bladder Cancer
por: Yang, Yong, et al.
Publicado: (2022)

Ubiquitination-Related Molecular Subtypes and a Novel Prognostic Index for Bladder Cancer Patients
por: Cai, Hai, et al.
Publicado: (2021)

The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator
por: Xu, Yanbo, et al.
Publicado: (2022)

Anterior Gradient 2 is a Significant Prognostic Biomarker in Bone Metastasis of Breast Cancer
por: Li, Jin-Jin, et al.
Publicado: (2022)

Immunohistochemistry-based molecular subtyping of triple-negative breast cancer and its prognostic significance
por: Leeha, Marisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mtvv0qh36smn111dn1j23p2et4